Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

# Table 2 Logistic regression analysis

30-d mortality n events: 7/219** 3-month mortality n events: 32/219** 6-month mortality n events: 64/219**
Category OR (95%CI) p OR (95%CI) p OR (95%CI) p
Palliative setting (metastatic or incurable malignancy) NC .998 1.6 (.3, 1.7) .596 1.6 (.6,4.6) .384
PS   .239   .050   < .001
PS 0 1   1   1
PS 1,2 1.6 (.1, 20.9) .719 1.3 (.5, 3.7) .932 2.7 (1.3, 5.9) .010
PS 3,4 6.4 (.1, 87.6) .163 4.8 (1.3, 17.9) .019 13.7 (4, 47.2) < .001
PESI   > .999   .096   .142
PESI Class I/II 1   1   1
PESI III/IV NC .998 4.1 (.7, 22.6) .107 0.97 (.4, 2.7) .943
PESI V 0.7 (NC) > .999 11.7 (1.3, 101.8) .030 3.3 (0.7, 15.4) .126
New/worsening symptoms 4 (.4, 40.2) .239 1.9 (.8, 4.8) .159 2.9 (1.4, 6) .005
WCC (cont.) * 1.3 (1.1, 1.6) .013 1.2 (1, 1.3) .008 1.1 (1, 1.3) .020
Creat (cont.) * .98 (.9, 1) .372 .9 (.9, .98) <.001 .98 (.96, .99) .014
1. Odds ratios are rounded to the first decimal (except when too close to 1) for simplicity. NC not computed. (cont.)*: continuous variable. **: number of patients with complete data in all categories